14 completed. 14 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 14 | Completed 14 |
| Phase 2 | 2 | Completed 2 |
Follow Ejaculatory Dysfunction: new trials by email Literature Review of Ejaculatory Dysfunction trials Research Report on Ejaculatory Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| On-demand Silodosin 4mg vs Dapoxetine 60mg in Treatment of Primary Premature Ejaculation sildosin 4mg, dapoxetine 60mg - Premature (Early) Ejaculation | Phase 2 / Phase 3 | Completed | Benha University | 95 | 2024-03-01 | 2025-07-23 |
| Evaluation of the Clinical Efficacy and Safety of Dapoxetine, Combined Dapoxetine With Folic Acid and Combined Dapoxetine With Vitamin B12 in Treatment of Patients With Premature Ejaculation Multi-Vitamin Tablets, Dapoxetine, Dapoxetine and folic acid. - Premature Ejaculation | Phase 3 | Completed | Sohag University | 120 | 2019-02-10 | 2019-09-11 |
| Glans Penis Augmentation by Hyaluronic Acid for Treatment of Premature Ejaculation Hyaluronic Acid - Premature Ejaculation | Phase 3 | Completed | Cairo University | 30 | 2016-08-19 | 2018-03-13 |
| Trial of PED-1 in Male Patients With Premature Ejaculation Clomipramine - Premature Ejaculation | Phase 3 | Completed | Symyoo | 159 | 2011-09-01 | 2012-10-03 |
| The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation Therapy Dapoxetine - Sexual Dysfunction, Physiological | Phase 3 | Completed | Janssen Research & Development, LLC | 285 | 2010-05-22 | 2024-11-19 |
| Concomitant Use of PriLigy in Men Treated for Erectile Dysfunction Placebo, Dapoxetine, PDE5I (phosphodiesterase-5 inhibitor) - Erectile Dysfunction, Sexual Dysfunction | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 495 | 2010-04-01 | 2013-01-24 |
| Efficacy and Safety of Paroxetine Daily Doses of 15 mg and 20 mg in the Treatment of Premature Ejaculation paroxetine, placebo - Premature Ejaculation | Phase 3 | Completed | MorePharma Corporation | 174 | 2008-08-01 | 2009-12-02 |
| Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation PSD502, contains a mixture of lidocaine and prilocaine, Placebo - Premature Ejaculation | Phase 2 / Phase 3 | Completed | Plethora Solutions Ltd | 256 | 2007-10-01 | 2016-09-26 |
| A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation Dapoxetine - Erectile Dysfunction | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1067 | 2005-03-01 | 2011-06-08 |
| A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation dapoxetine - Erectile Dysfunction | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1116 | 2004-12-01 | 2011-06-08 |
| A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature Ejaculation Dapoxetine - Sexual Dysfunction, Ejaculation | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 199 | 2004-11-01 | 2011-06-08 |
| A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation. Dapoxetine - Ejaculation | Phase 3 | Completed | Alza Corporation, DE, USA | 1294 | 2003-06-01 | 2011-05-19 |
| An Open-Label Study of the Long-Term Safety of Dapoxetine HCl in the Treatment of Rapid Ejaculation dapoxetine - Ejaculation, Erectile Dysfunction | Phase 3 | Completed | Alza Corporation, DE, USA | 1774 | 2011-05-19 | |
| A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation Dapoxetine - Ejaculation | Phase 3 | Completed | Alza Corporation, DE, USA | 1320 | 2011-02-11 |
Premature Ejaculation (14) · Sexual Dysfunction, Physiological (8) · Coitus (6) · Sexual Dysfunctions, Psychological (6) · Erectile Dysfunction (4) · Premature Birth (1)
Genital Diseases (14) · Genital Diseases, Male (14) · Male Urogenital Diseases (14) · Mental Disorders (14) · Urogenital Diseases (14) · Sexual Dysfunctions, Psychological (8) · Behavior (6) · Sexual Behavior (6) · Sexual Dysfunction, Physiological (6) · Female Urogenital Diseases and Pregnancy Complications (1) · Obstetric Labor Complications (1) · Obstetric Labor, Premature (1) · Pregnancy Complications (1)
dapoxetine (10) · Clomipramine (1) · Folic Acid (1) · Geritol (1) · Hyaluronic Acid (1) · Lidocaine, Prilocaine Drug Combination (1) · Paroxetine (1) · Phosphodiesterase 5 Inhibitors (1) · Prilocaine (1) · Vitamin B 12 (1)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (4) · Alza Corporation, DE, USA (3) · Benha University (1) · Cairo University (1) · Janssen Research & Development, LLC (1) · MorePharma Corporation (1) · Plethora Solutions Ltd (1) · Sohag University (1) · Symyoo (1)
South Korea (3) · Australia (2) · Egypt (2) · Mexico (2) · United States (2) · Argentina (1) · Belgium (1) · Canada (1) · France (1) · Malaysia (1) · Poland (1) · Russia (1) · Taiwan (1) · Thailand (1) · United Kingdom (1)
Culley Carson, MD (1) · Eusebio Rubio-Aurioles, M.D, Ph.D. (1) · Hamed A Hamed, MD (1) · Mohammed Abu El-Hamd, MD (1) · Whan-Seok Choi, MD,PhD (1)
PMID 21059176, PMID 16962882, PMID 20412423, PMID 19195772, PMID 19878447, PMID 20367770, PMID 23845016
2009 (1)